Abstract
A process at various pH values ranging from 4.5 to 7.5 for production of mycelia and extracellular polysaccharide (EPS) by P. linteus fermentation in pH-controlled shaken bioreactor was investigated. A two-stage pH control strategy in which pH value was kept at 6.5 for the first 24 h, and then switched to 4.5 was developed successfully to enhance simultaneously the cell growth and EPS production. The maximum cell density and EPS production reached 15.13 ± 0.1 g/l on day 6 and 6.74 ± 0.1 g/l on day 4, respectively. The anti- hyperlipemia effect of EPS and intracellular polysaccharide (IPS) extracted from mycelia were observed that both EPS and IPS can obviously reduce the serum triglyceride (TG), the blood cholesterol (TC) and serum low density lipoprotein (LDL) level, and increase the high density lipoprotein (HDL) level of the hyperlipemia mice. Polysaccharides from submerged cultivation of medicinal fungus P. linteus have favorable potency to develop anti-hyperlipermia drugs.
Avoid common mistakes on your manuscript.
Introduction
Phellinus linteus is one of the most well-know traditional medicinal mushrooms and has been widely used in Asian countries for years. P. linteus was known to be enriched in polysaccharides which have anti-tumor activity and other medicinal value. Many researchers have reported that polysaccharides isolated from P. linteus stimulated anti-tumor immunity, inhibited tumor growth and induced cytotoxic mechanism [1–3]. The methanolic extracts from the mycelial culture of P. linteus were also found having anti-hepatotoxins [4], and antioxidant activity [5]. However, it was little known that polysaccharides from submerged fermentation of P. linteus have anti-hyperlipemia activity.
In recent years, submerged fermentation of medicinal mushroom has received great interest in Asian countries as a promising alternative for efficient production of its valuable metabolites polysaccharide and other active products. There are many reports mentioning the various optimum submerged culture conditions of medicinal mushroom and their production of mycelial biomass and polysaccharide [6–9]. Within the various culture conditions, culture pH is one of the most important environmental factors in fungal fermentation, which can profoundly affect cell growth, product biosynthesis, mycelial morphology and broth rheology [10]. Submerged culture with pH control is an effective way to increase products of mycelia. In the submerged culture of medicinal mushroom Ganoderma lucidum, lee reported that shifting the pH from 3.0 to 6.0 at the initial phase of the exponential growth can improve cell growth and EPS production [11], Fang also reported that the initial pH varying within the range of 3.5–7.0 have a significant effect on the cell growth and polysaccharide biosynthesis of G. lucidum [12]. The initial pH 7.0 and 8.0 were best for polysaccharide production (EPS and IPS) and mycelial growth of medicinal mushroom Lyophyllum decastes, respectively [13]. The roughness and compactness of the pellets were affected by initial pH in the submerged culture of medicinal mushroom Cordyceps militaris [14]. It seems that different specials of medical mushrooms have obviously different pH control strategies for efficient production.
Recently, miniature bioreactors (MBRs) become an emerging field in which they have high-throughput capabilities and perform many cell cultivations in parallel [15, 16]. Shake flask is one of shaken bioreactors and usually used for multi-parameter parallel screening experiments, and culture optimization. In this paper, a novel shaken minibioreactor system which have low shear force and regulate pH automatically was designed to measure and control on-line pH, and employed to investigate the effect of pH on cell growth and extracellular polysaccharide (EPS) production of P. linteus fermentation, and a two-stage pH control strategy was developed to improve the productions of the mycelia biomass and EPS. Moreover, the anti-hyperlipemia activity of EPS and intracellular polysaccharide (IPS) extracted from mycelia have further been investigated in order to enlarge the medicinal value.
Materials and methods
Organism and medium
The strain of P. linteus was purchased from the collection bank of Huazhong Agricultural University (Hubei, China). The stock culture was maintained on potato-dextrose-agar slants. For Seed cultures, the medium composition was: glucose 20 g/l, yeast extracts 3 g/l, malt powder10 g/l. For fermentation, the medium consisted of sucrose 50 g/l, corn liquid 3 g/l, KH2PO4 10 g/l, MgSO4·7H2O 1 g/l, CaCl2·3 g/l and Vitamin B10.02 g/l.
Culture condition
The slants were inoculated with mycelia and incubated at 25 °C for 7 days, and then used for seed culture inoculation. The seed culture was grown in a 500 ml shake flask containing 100 ml of liquid medium and incubated at 25 °C on a rotary shaker (170 rpm) for 8 days. The fermentation cultivation was inoculated at 10%(v/v) of the above seed culture medium and kept at 25 °C and 160 rpm.
pH controlled cultivation in shaken minibioreactor
The shaken minibioreactor system was designed by Shanghai Guoqiang Bioengineering Equipment Co., Ltd China. Specially parallel 650 ml shaken bioreactors made of glass are used with a vertical port for the pH-probe. The intermittent feeding system was applied for parallel pH automatic controlled by base or acid addition. (See Fig. 1). The culture temperature and the inoculums size were the same as in shake flasks. Samples were taken every 24 h for the analyses of dry cell weight, EPS production, total sugar and residual sugar concentration. The shaken minibioreactor fermentation under each pH value ranging from 4.5 to 7.5 was repeated, and the data shown represent the mean values with the standard deviations.
The anti-hyperlipemia activity of EPS and IPS
For the determination of anti-hyperlipemia activity of IPS extracted from mycelia and EPS. Female SD mice (120–150 g, purchased from Laboratory Animal Facility of Third Military Medical University, China) were used, They were housed in a standard environmental condition and fed with high fat diets, contain vitelline flour 20%, lard 10%, bile salt pig 1% to induce hyperlipemia. After 3 weeks, animals were selected based on their body weight and allocated randomly to the following groups: hyperlipermia control, groups treated with 100, and 200 mg/kg per day of EPS, groups treated with 100, and 200 mg/kg per day of IPS and masculine groups treated with 60 mg/kg per day of Chinese drug products of Jiangzhiling (Chongqing Tongjunge Co. Ltd, China). All groups were treated once a day for 15 days. At the end of treatment liver weights were detected and regarded as absolute weight. Serum Low density lipoprotein (LDL), high density lipoprotein (HDL), triglyceride (TG) and the blood cholesterol (TC) were detected with an automated blood analyzer.
Determination of dry weight, residual sugar and total sugar
Dry cell weight (DW) was obtained by centrifugation (4,000×g, 10 min), washing the cells for three times with distilled water, and drying at 60 °C to a constant weight. The residual sugar was assayed by the dinitrosalicylic acid method (DNS method)[17] and total sugar was tested by phenol-sulfuric acid method [18].
Measurement of extracellular and intracellular polysaccharides
For the determination of EPS, after removal of mycelia by centrifugation (4,000×g, 10 min), the supernatant were concentrated at 60 °C to one-third of its total volume. The concentrated liquor was first precipitated with addition of 95% (v/v) ethanol by 30% (v/v), stored at 4 °C for 24 h and then separated by centrifugation at 4 °C (8,000×g, 15 min). The precipitate was discarded and the resulting supernatant was further mixed with addition of 95% (v/v) ethanol by 70% (v/v). Precipitation of EPS proceeded at 4 °C for 24 h and collected by centrifugation at 8,000×g for 15 min, discarding the supernatant. The precipitation of EPS was lyophilized and the weight of it was estimated [19].
For the determination of IPS, the dried mycelia were extracted by using hot water at 90 °C (2 h), and the supernatants were treatment with the method of EPS.
Results and discussion
Cell growth and EPS production at different pH control levels
In order to investigate the effect of pH control on mycelia growth and EPS biosynthesis, batch experiments were performed in shaken minibioreactor by varying pH value from 4.5 to 7.5. Profiles of residual sugar and total sugar concentration are shown in Fig. 2a and b. The consumption of total sugar obviously speeded up at pH 4.5 and produced more residual sugar for cell growth. Figure 2c and d shows the time profiles of cell growth and EPS production at different pH control levels. The results indicated that the maximum cell density at the pH value of 7.5, 6.5, 5.5, 4.5 was 4.67 ± 0.05, 14.43 ± 0.1, 14.75 ± 1.58, and 10.74 ± 0.42 g/l on day 4, 2, 3, and 3, respectively, while the maximum EPS production titer at the pH value of 7.5, 6.5, 5.5, 4.5 was 1.45 ± 0.06, 1.75 ± 0.05, 1.67 ± 0.14, and 6.8 ± 0.1 g/l on day 4, 4, 6, and 2, respectively. Kinetic parameters with batch fermentation under different pH control value were shown in Table 1. The growth rate of cell biomass at pH 6.5 was obviously quick than that of the other pH value, while the production formation rate of EPS at pH 4.5 was significantly improved compared with the other pH value. The above results indicated that the cell growth and EPS production were differently regulated under pH control levels. During the submerged fermentation of medicinal mushroom, Fang [12] also reported that lowering the initial pH from 6.5 to 3.5 gradually led to a higher production of extracelluar polysaccharide and a higher specific production of IPS.
Optimal pH-shift strategy for cell growth and EPS production
Based on the above batch experiments with pH control, an optimal pH-shift strategy was performed, in which the pH value was kept at 6.5 for the first 24 h, and then switched to 4.5 to enhance simultaneously the productions of mycelial biomass and EPS. The results were shown in Fig. 3. The maximum cell density and EPS production was 15.13 ± 0.1 g/l on day 6 and 6.74 ± 0.1 g/l on day 4, respectively. It is clear that, by adopting a simple and very effective strategy of pH-shift batch fermentation in the shaken minibioreactor, the cell mass and EPS production were enhanced simultaneously. The results obtained in this study were very useful for the simultaneous, highly efficient production of the biomass, and polysaccharide on a large scale.
The anti-hyperlipemia activity of EPS and IPS
The effect of EPS and IPS extracted from mycelia of medicinal mushroom P. linteus on the hyperlipemia activity is shown in Table 2. Compared with hyperlipemia control, all of high and low dose groups of EPS and IPS have can obviously reduce the serum TG, TC and LDL level and increase the serum HDL level of the hyperlipemia mice. Table 2 clearly showed that the decreasing rate of TG, TC and LDL level and increasing rate of HDL of high dose groups of EPS were higher than those of low dose groups, while the dose effects of IPS have no coincidence with the decreasing rate of TG and the increasing rate of HDL. Compared with masculine control, both EPS and IPS have similar anti-hyperlipemia activity. These results indicated that polysaccharides including EPS and IPS from submerged cultivation by medicinal mushroom P. linteus can significantly reduce the blood total cholesterol levels, which can used as an alternative source to product anti-hyperlipermia drugs.
Conclusion
In this work, a novel pH control strategy based on a shaken minibioreactor system for efficient production of mycelia and polysaccharide by medicinal mushroom P. linteus was developed. A two-stage pH-shift strategy in which pH value was kept at 6.5 for the first 24 h, and then switched to 4.5 was developed successfully to enhance simultaneously cell growth and polysaccharide production. The fundamental information obtained in this work is beneficial for further development of P. linteus submerged cultivation process on a large scale. Moreover, it was interesting that polysaccharides obtained from submerged cultivation of P. linteus have favorable potency to develop anti-hyperlipermia drugs.
References
Li G, Kim DH, Kim TD, Park BJ, Park HD, Park JI, Na MK, Kim HC, Hong ND, Lim K (2004) Protein-bound polysaccharide from Phellinus linteus induces G2/M phase arrest and apoptosis in SW480 human colon cancer cells. Cancer Lett 216:175–181
Kim GY, Lee JY, Lee JO, Ryu CH, Choi BT, Jeong YK, Lee KW, Jeong SC, Choi YH (2006) Partial characterization and immunostimulatory effect of a novel polysaccharide-protein complex extracted from Phellinus linteus. Biosci Biotech Bioch 70:1218–1226
Sliva D, Kawasaki J, Stanley G, Harvey K, Slivova V (2006) Phellinus linteus inhibits growth and invasive behavior of breast cancer cells through the suppression of Akt signaling. FASEB J 20:559–560
Kim BC, Jeon WK, Hong HY, Jeon KB, Hahn JH, Kim YM, Numazawa S, Yosida T, Park EH, Lim CJ (2007) The anti-inflammatory activity of Phellinus linteus (Berk. & M.A. Curt.) is mediated through the PKC[delta]/Nrf2/ARE signaling to up-regulation of heme oxygenase-1. J Ethnopharmacol 113:240–247
Park IH, Chung SK, Lee KB, Yoo YC, Kim SK, Kim GS, Song KS (2004) An antioxidant hispidin from the mycelial cultures of Phellinus linteus. Arch Pharm Res 27:615–618
Zou X, Sun M, Guo X (2006) Quantitative response of cell growth and polysaccharide biosynthesis by the medicinal mushroom Phellinus linteus to NaCl in the medium. World J Microb Biot 22:1129–1133
Xiao JH, Chen DX, Wan WH, Hu XJ, Qi Y, Liang ZQ (2006) Enhanced simultaneous production of mycelia and intracellular polysaccharide in submerged cultivation of Cordyceps jiangxiensis using desirability functions. Process Biochem 41:1887–1893
Fan LF, Soccol AT, Pandey A, Soccol CR (2007) Effect of nutritional and environmental conditions on the production of exo-polysaccharide of Agaricus brasiliensis by submerged fermentation and its antitumor activity. Lwt-Food Sci Technol 40:30–35
Lin ES, Sung SC (2006) Cultivating conditions influence exopolysaccharide production by the edible basidiomycete Antrodia cinnamomea in submerged culture. Int J Food Microbiol 108:182–187
Kim HM, Park MK, Yun JW (2006) Culture pH affects exopolysaccharide production in submerged mycelial culture of Ganoderma lucidum. Appl Biochem Biotech 134:249–262
Lee KM, Lee SY, Lee HY (1999) Biostage control of pH for improving exopolysaccharide production from mycelia of Ganoderma lucidum in an air-lift fermentor. J Biosci Bioeng 6:646–650
Fang QH, Zhong JJ (2002) Effect of initial pH on production of ganoderic acid and polysaccharide by submerged fermentation of Ganoderma lucidum. Process Biochem 37:769–774
Pokhrel CP, Ohga S (2007) Submerged culture conditions for mycelial yield and polysaccharides production by Lyophyllum decastes. Food Chem 105:641–646
Kim SW, Hwang HJ, Xu CP, Sung JM, Choi JW, Yun JW (2003) Optimization of submerged culture process for the production of mycelial biomass and exo-polysaccharides by Cordyceps militaris C738. J Appl Microbiol 94:120–126
Betts JI, Baganz F (2006) Miniature bioreactors: current practices and future opportunities. Microb Cell Fact 5:21–35
Fernandes P, Cabral JMS (2006) Microlitre/millilitre shaken bioreactors in fermentative and biotransformation processes a review. Biocatal Biotransfor 24:237–252
Miller GL (1959) Use of dinitrosalicylic acid reagent for determ ination of reducing sugar. Anal Chem 31:426–428
Dmgkahjkrpas F (1956) Colorimetric method for determination of sugars and related substances. Anal Chem 28:350–356
Xiao JH, Liu JW, Liu ZL, Wan WH, Fang N, Xiao Y, Qi Y, Liang ZQ (2004) Optimization of submerged culture requirments for production of mycelial growth and exopolysaccharide by Cordyceps jiangxiensis JXP 0109. J Appl Microbiol 96:1105–1116
Acknowledgments
Financial support was received from Chongqing Nature Science Foundation Program (contract no. CSTC, 2005BB1101).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zou, X., Guo, X. & Sun, M. pH control strategy in a shaken minibioreactor for polysaccharide production by medicinal mushroom Phellinus linteus and its anti-hyperlipemia activity. Bioprocess Biosyst Eng 32, 277–281 (2009). https://doi.org/10.1007/s00449-008-0241-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00449-008-0241-5